https://www.live-feeds.com/feed/what-men-should-know-about-the-us-government-s-latest-move-on-testosterone-therapyContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/what-men-should-know-about-the-us-government-s-latest-move-on-testosterone-therapyhttps://www.live-feeds.com/feed/what-men-should-know-about-the-us-government-s-latest-move-on-testosterone-therapy#u17483Mon, 29 Jun 2026 15:16:37 +0000The Department of Health and Human Services is seeking updates to testosterone replacement therapy labels. These changes follow a review of evidence regarding the safety and benefits of the treatments. The move aims to align labels with recent science and improve access to hormone drugs.What's confirmed:The U.S. Department of Health and Human Services is requesting revisions to labels on testosterone replacement therapies for men.The request for label changes follows a review of data and evidence concerning the safety and benefits of the therapies.The government wants labels to reflect more re https://www.live-feeds.com/feed/what-men-should-know-about-the-us-government-s-latest-move-on-testosterone-therapyhttps://www.live-feeds.com/feed/what-men-should-know-about-the-us-government-s-latest-move-on-testosterone-therapy#u12615Thu, 25 Jun 2026 09:07:21 +0000The Department of Health and Human Services and the FDA are proposing updates to testosterone replacement therapy labels. These changes follow a review of safety and benefit data. The goal is to make these treatments more accessible for men.What's confirmed:The Department of Health and Human Services is requesting revisions to testosterone replacement therapy labels.Proposed updates include revising warnings about prostate cancer risk.HHS plans to remove restrictions on therapy related to hypogonadism or enlarged prostate.An FDA panel recommended easing restrictions on testosterone replacement